CNBC World

Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.

Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.

This is a short WorldPing brief. The full report was published by CNBC World.

Read the full report at CNBC World

Related news